ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000068.1|Geldanamycin_1 # 2 # 9163 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.729	BGC0000068.1|Geldanamycin_1 	2	9163	+	Loose	660	58.5362	MexS	24.52	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GATCCCGAGGAGCTGTGCTCCCCGGAGTACTGGGTGCGGCATGTGCGTGGCGCGGTGCGGTTCCTCGACGGTGTCCGCACCCTGGCCGACGAGGGCGTGCGCACCCATCTGGAGCTCGGCCCGGACGGCGTGCTGACCGCGATGGGCCAGGACTGTCTGCCGGATGCGGGCGCGGAGGCGGATACCGCGTTCGCGGCGTTCGTGCCGTCCCTGCGTCCGGGCGTCCAGGAGGCCCACGCGACGCTGGCCGGGCTCGCGGGTCTGTACGTCCGGGGTGTGCCGGTGGACTGGGACGCGATGTTCGCCGGGTCCGGCGCCCGGCGCGTCGACCTTCCGACGTACGCCTTCCAGCATGAGCACTACTGGCTGGAGCGGCCCGCCGGGTCCGGCGACGTGGGCGCTGTGGGGCTCGGCGCGGCGGGCCATCCACTGCTGGGCGCGGTGGTGCAACTGCCGGAGACGGGCGGTGTGCAGCTCAGCGGGCGGCTGTCGGTGCGGGCCCAGCCCTGGCTGGGCGAACACATCATCTCCGGCACTGTACTGGTGCCCGGCACGGCCATGGTGGAGCTGGCGGTCCGCGCCGGGGACGAGACCGGCACCCCGGTGCTGGAGGAGCTGGTGATCGGTCAGCCGATGCTCCTGCCCGGCGACACCGCGCTGAGCGTGCAGGTCGTGGTGGGCACGGACGAGGGCGGGCGGCGCACGGTGCGGATCTACTCCCGCGCCGACGGGGCCACGGACTGGACCGAGCACGCCACCGGCACGCTCATGGCGCAGGGCCCGGCACCGCTGGACGGGGCCACCGGCGAGTGGCCGCCCGCGGAGGCCGAGCCGATCCCGGTGGAGGACTTCTACCGTTCGCTCGTGGACGCCGGCTATGCGTACGGACCGGCGTTCCGCGGGCTCGCCGCCGCGTGGCGCCTGGACGGTGAGGTCTTCGGCGAGGTGGCGCTGCCGGAGACGTACGCCGAGGAGGCCGAACGGTTCGGCATCCACCCGGCGTTGCTGGACGCCGCGCTGCACGCGGGCAACTTCTGCCTGCCCTCCGACCCGGCGCGGCAGGTGACCCTGCTGCCGTTCGCCTGGAACAACGTACGTCTGTACGCGGGCGGCGCGTCCGCGGTCCGGGTGCAGGTCCGCCCGGCCGGTGACGATGCCTTCTCGGTACGTCTGACCGATGGCTCGGGCCGGACGGTGGCCTCCGTGGAGGCGCTGACCCTGCGCGCGGTGGACCCGGCCCAGCTGGAGACGAACACGGCCGACGACGCGCTGTGGACGGTCCGGTGGAGCGAACACCCCCTGCCGGACGGCACGGTCTCCTGGGCCCCGCTCGGCGAGGCGGCGGCAGGAAGCGATACGGCCACCGAAGGCACCCTCCCCGACGTCCTCGTGGCCGACACGCGCACATGGGCCGAAGACCTCACCGAGCCGCTGCCCGCGCGGGCCCGGGAGCTGACCGGCCGCCTGCTGGAGGAGATCCAGCGGTGGGTCACCGACGACGCCATGGCCGGGACGCGGCTGGCCGTGGTCACCCGCGGCGCGGTCGCCGTGCACGGCGACGCCGAGGTCACCGACCCGGCCGCCGCCGCGGTCTGGGGTCTGGTCCGCTCGGCCCAGGCCGAACACCCGGGGCGGCTGGCCCTGGTGGACGCCGACGGCGCGTGCGAGGAGTTGCCCGCGGGTGTGTGGTCCGGGGACGAGCCCCAACTGGCGGTGCGCGGTGGCACCGTATGGGTGCCACGCCTGGCCCGGGTGGAGCCGGGCCTGCGTGTGCCCGAGCAGCGGTCGTGGCATCTGGACTCGGCCGAATACGGCACGCTGGACAATCTGGCGCTGTTGCCCGACGAGGCCCGGACCGCACCGCTGGAGGCCGGTCAGGTGCGGATCGAGGTCCGCGCCGCCGGGCTCAACTTCCGCGATGTCCTGGTGGCCCTCGGTATGTATCCGGGCCGGTCGGTGATCGGCACGGAGGGGGCCGGTGTGGTGACCGAGGTCGGCCCGGACGTGGCGGACCTGGCCGTGGGCGACCGGGTGATGGGCCTGTTCTCCGGCTCGTTCGGCCCGCTGGCCACCGCCGACGCGCGCACGGTGATCCGGATGCCGGAGGGCTGGTCGTTCGGCACGGCGGCCGGAGTGCCGGTGGCGTATCTGACGGCGCTGTACGCGTTGCAGGACCTCGGGAAGGTGCGGCCGGGCGAGACGGTGCTGGTGCACGCCGCAGCGGGCGGTGTGGGCATGGCCGCCGTCCAGCTCGCACAGCACCTCGGCGCCACCGTCCTGGGCACCGCCCACCCCTCCAAACACCACGCCCTCCACCGGCTCGGCGTGCCCGCCGAACGGCTCGCCTCCAGCCGCGACCTCGGCTACGCCGGCACCTTCCCCACCGCCGACGTCGTCCTCAACTCCCTCACCGGCGAACACATCGACGCCTCCCTCGGCCTTCTCGGCCCCGGCGGCCGGTTCCTGGAGATGGGAAAGACCGACCTGCGGGAGCCCGGCGAGGTCGGGGCGCGCCATCCCGAGGTCACCTACCGGGCGTTCGACCTCGGTGGTGAGGCCCCCGCGGACCGGGTGCGGGAGTTGCTGCGCCAGCTGGTGGAACTGTTCGAGGCGGGCCGGATCGAGCCGCTGCCGGTACGGCACTGGGACATCACCCGAGCCCCGGAGGCGTTCCGCTGGATGAGCCAGGGCCGTCACACCGGCAAGATCGTGCTCACCATCCCCCGCACCCTCGACCCCGACGGCACCGTCCTGGTCACCGGCGGCACCGGCACCCTCGGCGCCACCATCGCCCGCCACCTCATCACCCACCACGGCGCACGCCACCTGCTCCTCGTCAGCCGCCAAGGCCCCGACGCCCCCGGCGCGACCGAACTCGCCACAGAACTCTCCGAACTCGGTGCCACCGTCCACATCACCGCCTGCGACACCGCCGACCGCCACCACCTCACCACCACCCTCGCCAACATCCCACCCGACCATCCACTGACAGCCGTCATCCACACCGCCGGAACCCTCGACGACGGCATCCTGACCGCCCTCACCCCCCTACGACTCGACACCGTCTTCCGCCCCAAAATCGACGCGGTCACCCACCTCCACGACCTCACCCGCGATCAGGACTTGGCGGCGTTCGTGGTGTACTCGTCGGCCGCCGGAGTGCTCGGCGGGCCCGGCCAGGGCAACTACTCGGCCGCCAACGCCTATCTGGACGGCCTCGCGCAGTGGCGGCGTGCGCGTGGGCTTCCCGCCACCTCGCTGGCGTGGGGCATGTGGGCAGAGACAAGCGGTATGACGGCCGGGCTGGGCTCCGGCGATCTGCACCGGGTGCGCCGCGGTGGCATCGTCGGGCTGTCCACGGCGGAGGCGCTGGACCTGTTCGACCGGTCGGTGGCGTCGGGGCTGTCGCTGCTGATGCCATTGCGGTTCGACTTCGCCGCACTCGGCGCGGAGGCCACGGAGCCACCGCCGCTGCTGCGCGGTCTGGTCCGGCCCGCCCGGCGTACGGCCCGGCCGGTGCCGAAGGCCGCTGAGGGCGGGCTCGTACAGCGACTGGCCGGGTTGGCCACGGCCGAACAGCAGCGGCTGCTCGTCGAGTTGACCCGCGAAGAGACCGCTTCGGTTCTCGGGTTCCCCACCGTCGACCCCATAGGTCCGGAACAGGCGTTCCGGGACCTGGGAATCGACTCGCTGACCGCGGTGGAGCTCCGCAACCGCCTCAACACGGCCACCGGGCTACGGCTGCCCGCGACGCTGGTCTTCGACCACCCGACGCCTCAGGCCACCGCCGAGTTCCTGCGCGACCAGCTGGGCGGGCGGACCGTGGAGGCCGCGCCCCGGCCGACCCACCGCCGCCGGTCCGCTCCGGACGAAGCCGAGGATCCGGTCGTCGTGGTGGGCATGGGCTGCCGGCTGCCCGGCGACGTCCGCACCCCCGAGGACCTGTGGCGGCTGGTGGCCGCCGGAACCGACGCGATCGGCCCGTTCCCGCAGGACCGGGGGTGGGACCTGGCCGGGCTGTTCGACCCCGACCCGGACGCCGTGGGCAAGTCCTACGTACGCGAGGGCGGATTCCTCACCGACGCGGGTGGATTCGACGCCGCCTTCTTCGGCATCTCCCCGCGCGAGGCCCTGTCGATGGACCCGCAGCAGCGCGTATTGCTGGAGACCGCCTGGGAGACCCTGGAAGGCTCCGGGATTGTTCCCACGTCACTGCGCGGCCAGGAGGTCGGCGTCTTCGTCGGCGCCAGCGGCCAGGGGTACGGCACCGGCCCCGGCGCGGCGCCGGAAGGCTTGGAGGGCTACCTCGGGGTGGGCGGCGCGACGAGCGTGGCGTCGGGCCGGGTGTCGTACACCTTCGGCCTGACCGGTCCCGCGGTGACGGTGGACACGGCGTGCTCCTCCTCGCTGGTGGCCATCCACCTCGCCGTACAAGCCCTGCGCTCCGGCGAGTGCACGATGGCACTCGCCGGGGGCGTCGCCGTCATGGGCCAGCCCGGCGCCTTCGTGGAGTTCTCCCGCCAGCGCGGTCTGGCGTCCGACGGCCGCTGCAAGTCCTTCGGCGAGGGCGCCGACGGCACCAACTGGTCCGAGGGCGTAGGGCTCTTGCTGCTGGAACGGCTGTCCGACGCCCGCCGCGACGGCCACGAGGTACTGGCCGTGATCCGTGGCACGGCGGTCAACCAGGACGGCGCAAGCAACGGCCTCACCGCGCCCAACGGCCCCTCCCAGCAACGGGTGATCCGGCAGGCACTGGCCAACGCCGGGCTGACAGCGGCCGATGTGGACGCCGTCGAGGCCCATGGCACCGGCACCGCACTCGGCGACCCCATCGAGGCCCAGGCACTCCTGGCCACCTACGGCCAGGAGCGACAGGGTGACGAGCCGCTGTGGCTCGGATCGCTGAAGTCCAACATCGGCCACACCCAAGCGGCCGCGGGCGTGTCCAGCGTCATCAAGATGGTGCTGGCGCTGCGGCACAGCACGCTTCCGCGCTCCCTGCACGCCGACGAACCCACCGCCCAGGTGGACTGGACGTCGGGCGCGGTGTCCCTGCTCGCCGAGGCGCGCCCCTGGCCGGTGAACGGACACCCCCGCCGCGCCGGGATCTCCTCCTTCGGCGTCAGTGGGACGAACGCACACGTGGTCCTGGAACAGGCACCGAACCCCGAGCCCGCGCCGAAGGTGGACGACGGTACGGAGATCCCCGGTCTGGTCGCCACCGGCGGAATCGCCCCCTGGGTGCTGTCGGCCAAGACCGCCACAGCCCTGCGAGCTCAGGCCCAATGCCTCCTGGACCACCTGGAATCCGGCGCCGACGCACACCCCGTGGACATCGGCTGGTCCCTGGCCACCACCCGCACCCTCCACGACCACCGCGCCGTCATCCTCGCCGACACCACCGCCGAAAGCACTGAGACCACGGCCGCCCTCACCGCCCTCGCGAGCGGGCAGCCGCACCCCCGCCTCACCACCGGCCACGCCACCACCCACGGCAAAACCGCCTTCGTCTTCCCCGGCCAAGGCGCCCAATGGGTCGGAATGGGAGCCCAACTCCTCACCACTTCCCCCGTCTTCGCCGAACGCCTCCACGAATGCGCCGCGGCCCTGGCCCCGTACACCGACTGGAACCTCATCGACGTCATCACCGGCGCACCCGACGCGCCCTCGCTCGACCGTGTCGATGTCGTACAACCCGCCACCTTCGCTGTGGTCGTCTCCCTGGCCGCACTGTGGCAGTCCTGCGGCATCCACCCCGACGCCGTCATCGGCCACTCCCAGGGCGAAATCGCCGCCGCCTGCGTCGCCGGACATCTCACCCTCCCCACCGCCGCCAAAATCATCACCCTCCGCAGCCAAACCATCGCCCACCATCTGGCCGGACACGGCGGCATGATGTCGCTCGCCGCCCCCGCCGACACCATCGACCTCACCAACTGGCACGGCAAACTCTGGATCGCCGCACACAACGGCCCCAACGCCACCGTCATCGCAGGCGACACCGACGCCCTCCATGAGCTTCACGCTCACTACACCGACCAGGGCATCAGGGCCCGCATCATCCCCGTCGACTACGCCTCCCACACCGGACACGTCGACACCATCGAGGACGAACTCCACCAGGCTCTGGCCGACACCACCACCGAGCCCGGCACCATCCCCTGGCTCTCCACCGTCACCGGCCAGTGGATCGAACCCAATACCGCCGACGGCGACTACTGGTTCCGCAACCTGCGCCAGACCGTGCGGTTCGACGCCACCGTCCGCACCCTCGCCGACGACGGCTACCGCACCTTCATCGAAGTCAGCCCCCACCCCGTCCTCACCACCGCCATCCAAGAAACCCTCGAAGCAAACCAAACCCCCCACACCACCATCACCGGCACCCTCCGCCGCAACGACGACACCCCCACCCGATTCCTCACCCACCTCGCAGAACTGTCCACCAGGGGAACACCAATGGACTGGCCCACCGCGTACACCGGATCACAACCCTCCCAAATCCCGCTGCCCACCTACCCCTTCCAACACGAGACGTTCTGGCTGGACCGTGGCGGTCCGGGCGATGTCCGTGCCGTGGGTCTCGAGGACACCGGCCACCCGCTGGTCGGGGCCGTGGTGAGCGTGCCCGACACCGGAGGTGTGCTGCTCACCGGGCGTCTCTCCCTGCCCACCCACCCCTGGCTGGCCGACCACGCGGTCTCCGGCACCGTGCTGCTCCCGGGTACGGCGATGGTCGAGCTGGCGGTGCGTGCCGGGGACGAGGCGGACACCCCCGTACTGGAGGAGCTGGTCATCAGCCGGCCGATGACGGTGCCGGACGAGGGCACCCTGCATGTCCAGGTGCTCGTCGGCGGAGAGGAGCGCGGGCGCCGCAAGGTGGGGGTCTACTCCCGCCCGGAGGGCATACGGGAGTGGACCGAGCACGCCACCGGCACGCTGACCGCGGGGGCCGCCGTCCCGCCGGAAGAGGCCGAGGCCGCGCTGCCGTGGCCGCCCGAGGGTGCGGAGCCCGTGGCCCTGGAGGGGTTCTACGAGCACCTGGCCGAGGTCGGGTACGAGTACGGCCCGGCGTTCCGTGGCCTGAGGGCGGTGTGGAAGCGGGACGACGAGGTGTTCGCCGAGGTGTCGGTGCCGGAGGAGCAGACCGGGGTGGCCGGGCGGTTCGGCATCCATCCGGCGCTGCTGGACGCCACTCTGCACGCCGGGAACTTCTGCTTCCAGTCCGCTGGTGAGCGGCCCACGATGCTGCCGTTCGCGTGGACCGACGTACGGCTCCACGCCGTGGGCGCCACCGCGGTGCGGGTGCGCGCGACGGTGTCCGGCGGGGACGGGTTGTGTGTGCGGATCACCGATCCGCGGGGTGTGCCGGTCGCCACGATCGGCTCCCTCCAGCTCCGGGAGACCACACCCGACCAGCTGCGCGCGCTGGCCGCCGCGTCGGGCGGCAATGCCCTGTGGGCGGTCGAATGGGCCGAATGCGGGCTCGGCGCCACCGAAGCGCGCTGGGCCACGGTCGGGGAGAGCGGGCTCCCGGACGCCCCGTCGAGCTATGCCGATGTCCCGGAGGTCGCGGAGGCCGGGGAGCGGCCCGAGGTGCTCGTCGCCGACGTGTCCGCCTGGGTCCCCGAACAGACCGGGCCCATCGACCGTACGCACGCGCTCTGCGCCCGGGTGCTGGATCTGCTGCGGGAGTGGGTGGACCGGCCCGAACTGGCGGACACCCGCCTGGCCGTCCTGACCCGCGGCGCCATGGCCGTCCACGACACCGCCGAGGTCACCGACCCGGCCGCGGCCGCGGTCTGGGGTCTGGTCCGCTCCGCCCAGTCCGAGCACCCCGGCCGGGTCCGGCTCATCGACGTCGACGGCCACTCCCACCAGACCCTGCCCACAGCGCTCACCACGGCCGAAGCCCAACTCGCCCTTCGCGACACCACCGCCTACACGCCCCATCTGACCGCCGCGCCCACCGGCACACCGTCCCAGCCCCTCGCCCTGGCCCCGGAAGGGACCGTTCTCATCACCGGTGGCACCGGCACCCTCGGCGCCCTCACCGCCCGCCACCTCATCACCCAGCACGGCGCGCGCGACCTCCTCCTGGTCAGCCGCCAGGGGCCCGATGCCCCCGGCGCGGCCCGGCTCGGCGAGGAGCTGACGCGGCTCGGCGCCCGTATCCACATCGCCGCCTGCGACACCGCCGACCGCGACCAACTCGCCGCCGTCCTTGACGGCATCCCCGCCGACCATCCACTGACCGCCGTGGTCCACACCGCGGGGACCCTGGACGACGCCCTGCTCACCGATCTCACCCCGCGGCGCCTCGACACCGTTCTGCGCCCCAAGGTCGACGCCCTCACCCATCTCCACGACCTCACCCGCGATCTCGACCTCGCGGCCTTCGTCGTCTTCTCCTCCGCCACCGGCGTCCTCGGCACCCCCGGCCAGGCCAACTACGCCGCCGCCAACACCTACGCCGACGCGCTCGCCCAGCAGCGCCACGCCGCCGGGCTCCCCGCCACCTCACTCGCCTGGGGCCTGTGGGAGACCACCAGCGCCCTCACGGCCGGTATGACCACCGCCCAGCAGCAACGGACCCGGCACAGCGGTGTCATCCCCCTGACCGACGCCGACGGTATGCGCCTCCTGGACACCGCGCTCACCACCCCGCACCCCCATCTCATCCCCCTCGAGCTGGACCTCGCGGCCCTCCGGAACAACACCGACCCCCACACACTCCCGCCCCTCCTGCGCGGCCTCATCCGCGGCCACCACCGCCCCACCGCCCACGCCTCGGCCCGGCCCGACGCCGCCCCGTCCCTCGCCCAAGAGCTGGCCGCGCTCGACCCGGCCCAGCGGCACCAGCGCCTGACCGAACTGGTCCGCGCCGAGGCCGCGGCCGTCCTCGGACACCCCACCCCGGACGCGGTGGGCCCGAACGACCCGCTGTTCGAGATCGGGTTCGACTCGCTGACCGCGGTGGAACTGCGCAACCGCCTCAACGCGGCCACCGGCCTCCAGCTCGCGGCGGCGATGCTGTTCGACTACCCCACCCCGTCGATGGCCGCCGAGCACCTCCAGGAGCAGCTCGCGCTGGATGCCACGAACGCACCCGTGGCGGCCCGAGAAGCGGCGGAAGACGACGACCAGAACACGGAGAGGTGA	DPEELCSPEYWVRHVRGAVRFLDGVRTLADEGVRTHLELGPDGVLTAMGQDCLPDAGAEADTAFAAFVPSLRPGVQEAHATLAGLAGLYVRGVPVDWDAMFAGSGARRVDLPTYAFQHEHYWLERPAGSGDVGAVGLGAAGHPLLGAVVQLPETGGVQLSGRLSVRAQPWLGEHIISGTVLVPGTAMVELAVRAGDETGTPVLEELVIGQPMLLPGDTALSVQVVVGTDEGGRRTVRIYSRADGATDWTEHATGTLMAQGPAPLDGATGEWPPAEAEPIPVEDFYRSLVDAGYAYGPAFRGLAAAWRLDGEVFGEVALPETYAEEAERFGIHPALLDAALHAGNFCLPSDPARQVTLLPFAWNNVRLYAGGASAVRVQVRPAGDDAFSVRLTDGSGRTVASVEALTLRAVDPAQLETNTADDALWTVRWSEHPLPDGTVSWAPLGEAAAGSDTATEGTLPDVLVADTRTWAEDLTEPLPARARELTGRLLEEIQRWVTDDAMAGTRLAVVTRGAVAVHGDAEVTDPAAAAVWGLVRSAQAEHPGRLALVDADGACEELPAGVWSGDEPQLAVRGGTVWVPRLARVEPGLRVPEQRSWHLDSAEYGTLDNLALLPDEARTAPLEAGQVRIEVRAAGLNFRDVLVALGMYPGRSVIGTEGAGVVTEVGPDVADLAVGDRVMGLFSGSFGPLATADARTVIRMPEGWSFGTAAGVPVAYLTALYALQDLGKVRPGETVLVHAAAGGVGMAAVQLAQHLGATVLGTAHPSKHHALHRLGVPAERLASSRDLGYAGTFPTADVVLNSLTGEHIDASLGLLGPGGRFLEMGKTDLREPGEVGARHPEVTYRAFDLGGEAPADRVRELLRQLVELFEAGRIEPLPVRHWDITRAPEAFRWMSQGRHTGKIVLTIPRTLDPDGTVLVTGGTGTLGATIARHLITHHGARHLLLVSRQGPDAPGATELATELSELGATVHITACDTADRHHLTTTLANIPPDHPLTAVIHTAGTLDDGILTALTPLRLDTVFRPKIDAVTHLHDLTRDQDLAAFVVYSSAAGVLGGPGQGNYSAANAYLDGLAQWRRARGLPATSLAWGMWAETSGMTAGLGSGDLHRVRRGGIVGLSTAEALDLFDRSVASGLSLLMPLRFDFAALGAEATEPPPLLRGLVRPARRTARPVPKAAEGGLVQRLAGLATAEQQRLLVELTREETASVLGFPTVDPIGPEQAFRDLGIDSLTAVELRNRLNTATGLRLPATLVFDHPTPQATAEFLRDQLGGRTVEAAPRPTHRRRSAPDEAEDPVVVVGMGCRLPGDVRTPEDLWRLVAAGTDAIGPFPQDRGWDLAGLFDPDPDAVGKSYVREGGFLTDAGGFDAAFFGISPREALSMDPQQRVLLETAWETLEGSGIVPTSLRGQEVGVFVGASGQGYGTGPGAAPEGLEGYLGVGGATSVASGRVSYTFGLTGPAVTVDTACSSSLVAIHLAVQALRSGECTMALAGGVAVMGQPGAFVEFSRQRGLASDGRCKSFGEGADGTNWSEGVGLLLLERLSDARRDGHEVLAVIRGTAVNQDGASNGLTAPNGPSQQRVIRQALANAGLTAADVDAVEAHGTGTALGDPIEAQALLATYGQERQGDEPLWLGSLKSNIGHTQAAAGVSSVIKMVLALRHSTLPRSLHADEPTAQVDWTSGAVSLLAEARPWPVNGHPRRAGISSFGVSGTNAHVVLEQAPNPEPAPKVDDGTEIPGLVATGGIAPWVLSAKTATALRAQAQCLLDHLESGADAHPVDIGWSLATTRTLHDHRAVILADTTAESTETTAALTALASGQPHPRLTTGHATTHGKTAFVFPGQGAQWVGMGAQLLTTSPVFAERLHECAAALAPYTDWNLIDVITGAPDAPSLDRVDVVQPATFAVVVSLAALWQSCGIHPDAVIGHSQGEIAAACVAGHLTLPTAAKIITLRSQTIAHHLAGHGGMMSLAAPADTIDLTNWHGKLWIAAHNGPNATVIAGDTDALHELHAHYTDQGIRARIIPVDYASHTGHVDTIEDELHQALADTTTEPGTIPWLSTVTGQWIEPNTADGDYWFRNLRQTVRFDATVRTLADDGYRTFIEVSPHPVLTTAIQETLEANQTPHTTITGTLRRNDDTPTRFLTHLAELSTRGTPMDWPTAYTGSQPSQIPLPTYPFQHETFWLDRGGPGDVRAVGLEDTGHPLVGAVVSVPDTGGVLLTGRLSLPTHPWLADHAVSGTVLLPGTAMVELAVRAGDEADTPVLEELVISRPMTVPDEGTLHVQVLVGGEERGRRKVGVYSRPEGIREWTEHATGTLTAGAAVPPEEAEAALPWPPEGAEPVALEGFYEHLAEVGYEYGPAFRGLRAVWKRDDEVFAEVSVPEEQTGVAGRFGIHPALLDATLHAGNFCFQSAGERPTMLPFAWTDVRLHAVGATAVRVRATVSGGDGLCVRITDPRGVPVATIGSLQLRETTPDQLRALAAASGGNALWAVEWAECGLGATEARWATVGESGLPDAPSSYADVPEVAEAGERPEVLVADVSAWVPEQTGPIDRTHALCARVLDLLREWVDRPELADTRLAVLTRGAMAVHDTAEVTDPAAAAVWGLVRSAQSEHPGRVRLIDVDGHSHQTLPTALTTAEAQLALRDTTAYTPHLTAAPTGTPSQPLALAPEGTVLITGGTGTLGALTARHLITQHGARDLLLVSRQGPDAPGAARLGEELTRLGARIHIAACDTADRDQLAAVLDGIPADHPLTAVVHTAGTLDDALLTDLTPRRLDTVLRPKVDALTHLHDLTRDLDLAAFVVFSSATGVLGTPGQANYAAANTYADALAQQRHAAGLPATSLAWGLWETTSALTAGMTTAQQQRTRHSGVIPLTDADGMRLLDTALTTPHPHLIPLELDLAALRNNTDPHTLPPLLRGLIRGHHRPTAHASARPDAAPSLAQELAALDPAQRHQRLTELVRAEAAAVLGHPTPDAVGPNDPLFEIGFDSLTAVELRNRLNAATGLQLAAAMLFDYPTPSMAAEHLQEQLALDATNAPVAAREAAEDDDQNTER	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	900.59	gnl|BL_ORD_ID|1039|hsp_num:0	1041			81	1011	ciprofloxacin; trimethoprim; chloramphenicol
BGC0000068.1|Geldanamycin_2 # 9172 # 9945 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AAG;rbs_spacer=6bp;gc_cont=0.686	BGC0000068.1|Geldanamycin_2 	9172	9945	+	Loose	910	26.5646	mtrE	36.59	3000812	protein homolog model	n/a	n/a	macrolide antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTTCGACGTGGCGAAGTACCTGCGGCGCATCGGGGTGGAGTCCATACCCGCACCAACTCTGGACACCCTCCGGCACCTGCACAAACGGCATCTCATGGCGGTCCCGTACGACAACTCGACGGCCCCCGACCGGCTCCCGGCCTCGCGGCATCTGACGAACGTCCCGCTGGACCTGGTGTTCGAGCATGTGGTGACCGAGGGCCATGGCGGAGTGTGCTACGAGCTCAACCGGCTGTTCCACACGCTGCTGGCCGAACTCGGCTACGACGTGCGCATGGTGGCGGCGGCGGTACGGCAGGCGAACGGGGCCTTCGGCCCGGAGCGCGAGCACACCTTCGACCTGGTCCGCCTCGACGGGCGGACCCACCTGGTGGACGTCGGTTTCCCCGGGCCGTCCTATTCGGAGCCGCTGCGCCTGTCCGAGGAGGAGCAGCACCAGTACGGCTGTGCCTACCGCGTGACCGAACACGACGGCTACCGGGTGGTGGAACGGCGGCCCAAGGAGAGCGGCTGGCAGCCGGTGTACCGGTTCCGGCCGGAGCTGGCCGACCCGTCCGGCTGGGACGCGGTGCGGCTGGACAGCCTGGACGACTACGCACAGGACTCGGTGCTCGCCGGGACCACCTTCCGCAGCCGGGCCACGGACAACGGAAAGATCGTGCTGATCGGCAGGCGCTGCTTCACCGTCGAGGACGGGGTGGAGCGCACCAAGGTGCTGGTGAAGGCGGACGAGTTCCAGGACACGGTCGATCTGATCCTGGCGGGCGAATGA	MFDVAKYLRRIGVESIPAPTLDTLRHLHKRHLMAVPYDNSTAPDRLPASRHLTNVPLDLVFEHVVTEGHGGVCYELNRLFHTLLAELGYDVRMVAAAVRQANGAFGPEREHTFDLVRLDGRTHLVDVGFPGPSYSEPLRLSEEEQHQYGCAYRVTEHDGYRVVERRPKESGWQPVYRFRPELADPSGWDAVRLDSLDDYAQDSVLAGTTFRSRATDNGKIVLIGRRCFTVEDGVERTKVLVKADEFQDTVDLILAGE	MNTTLKTTLTSVAAAFALSACTMIPQYEQPKVEVAETFQNDTSVSSIRAVDLGWHDYFADPRLQKLIDIALERNTSLRTAVLNSEIYRKQYMIERNNLLPTLAANANGSRQGSLSGGNVSSSYNVGLGAASYELDLFGRVRSSSEAALQGYFASVANRDAAHLSLIATVAKAYFNERYAEEAMSLAQRVLKTREETYNAVRIAVQGRRDFRRRPAPAEALIESAKADYAHAARSREQARNALATLINRPIPEDLPAGLPLDKQFFVEKLPAGLSSEVLLDRPDIRAAEHALKQANANIGAARAAFFPSIRLTGSVGTGSVELGGLFKSGTGVWAFAPSITLPIFTWGTNKANLDVAKLRQQAQIVAYESAVQSAFQDVANALAAREQLDKAYDALSKQSRASKEALRLVGLRYKHGVSGALDLLDAERSSYSAEGAALSAQLTRAENLADLYKALGGGLKRDTQTGK	55.03	gnl|BL_ORD_ID|409|hsp_num:0	453			846	969	erythromycin; penicillin; azithromycin
BGC0000068.1|Geldanamycin_3 # 9963 # 11585 # 1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=AAG;rbs_spacer=9bp;gc_cont=0.728	BGC0000068.1|Geldanamycin_3 	9963	11585	+	Loose	550	120.553	Nocardia farcinica rox	32.76	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	GTGGACGTCGCGCGGGACACGGACAACGGCGGGCCCAAGACCGATGTGCTGATCGTCGGGTACGGACCGGTGGGGCAGCTGCTGTCGGTGCTGCTGGCCCAGCGCGGCCGCCGGGTGACGGTGGTGGAGCGCTGGCCGGAGCCGTACCGGCACCCCCGGGCGGTCGGGTTCGACAGTGAGGCCGCGCGCATCCTGGCCTCGGCCGGGATCGGCGACTCGCTCGAGAAGTTCACCGAACCCGCGCGGGACCACGCCTGGCAGAACACCAAGGGCGAGACGCTGATCGACCACGAGGTCGCCAACCGGGGGCACTGCACCTGGCCGGAGGCGCTGTCGGCCTATCAGCCGGCCCTGGAGTCCGCACTGATCGAACACGGGGCGACGCTGCCGCGGCTGCGGGTGCTGCGCGGCTACGAGGCGGTGGGACTCGCGGACAACGGTGACCGGGTGACCTTGACCGTGGTCGGTCCGGACGGCGAGAGGACGGACCTCATCGCTTCGTGGGTGGTCGGCTGCGACGGCGCCAACAGCCTGGTGCGGGCGAGTGTCGGCACCACGGTGACGGACCTCGACTTCTCCTACGACTGGCTGATCTGCGATGTGCGGCTGCATGAGCACCGCGAGTTCCGGCCGAACAATCTGGAGATCTGCGATCCGGCCCGCCCGCGGACCGCGGTGTCCGCGGGGCCCGGACACCGGCGGTACGAGTTCATGCGGGTGCCCGCGGACGACCCCGCGCACTTCGGCACCGTGGAGAGCGCGTGGGAGCTGCTGCGGCTGTTCGACGTGACGCCCGACAACGGCGTCCTGGACCGGCATGCGGTCTACACCTTCCAGGCCCGCTGGGCGGAGCACTGGCGGGCCGGACGGCTGCTGCTGGCCGGGGACTCGGCGCACCTCATGCCGCCGTTCGCGGGGCAGGGCATGTGCTCCGGATTCCGTGACGCGGCGAATCTGGCCTGGAAGCTGGACCTGGTGCTGAGCGGGCACGCGGCACCGGCGCTGCTGGACACCTACACCAGCGAGCGGCGGGCGCATGTGCGGCACGCGGTGGAGATGTCCGTGGGCCTGGGCCGGGTGGTGTGCATGGCGGACCCGGCCGCGGCGGCGGACCGGGACGCGGCGATGCTGGCCGCGCGGAAGCGGAACATCGGGCCGAGCGCCGCGCGCCGCTCGGTGGTGCGCCCGCTCGTGGACGGGTTGCTGCGGCGGGACGGGCAGGGCCGGCCGGCGCCGTACGCCGGACAGGCGGCCCCACAGTGGCGGGTGGGCCGCGCGGGCGGCACCGGGCTGTTCGACGATGTGGTGGGCACCGGTTTCATCCTGCTGTACGGCGAGGACGTGGTCCCGGCGCTGGACGCGCGGCAGCTGACGTTCCTCGACAACATCGGGGCCCGGCTGGTGCGTGTGGTGCGCGCGGAAACGCCCGCGGCCGACCTGGAACCAGGGGACGCGCGGGACGTGGAGGGCCGGTATCTGCCGTATCTGTCGGAGATGGGCGCGCTGGCGGTGCTGGTACGCCCGGACTTCTACGTGTTCGGCATCGCGGGCGACAAGGCCGAACTGCCCTCGCTGGTGGACGACTTGGCGGAACAACTCACCCCGACCGCCGCCCCGTCCTGA	MDVARDTDNGGPKTDVLIVGYGPVGQLLSVLLAQRGRRVTVVERWPEPYRHPRAVGFDSEAARILASAGIGDSLEKFTEPARDHAWQNTKGETLIDHEVANRGHCTWPEALSAYQPALESALIEHGATLPRLRVLRGYEAVGLADNGDRVTLTVVGPDGERTDLIASWVVGCDGANSLVRASVGTTVTDLDFSYDWLICDVRLHEHREFRPNNLEICDPARPRTAVSAGPGHRRYEFMRVPADDPAHFGTVESAWELLRLFDVTPDNGVLDRHAVYTFQARWAEHWRAGRLLLAGDSAHLMPPFAGQGMCSGFRDAANLAWKLDLVLSGHAAPALLDTYTSERRAHVRHAVEMSVGLGRVVCMADPAAAADRDAAMLAARKRNIGPSAARRSVVRPLVDGLLRRDGQGRPAPYAGQAAPQWRVGRAGGTGLFDDVVGTGFILLYGEDVVPALDARQLTFLDNIGARLVRVVRAETPAADLEPGDARDVEGRYLPYLSEMGALAVLVRPDFYVFGIAGDKAELPSLVDDLAEQLTPTAAPS	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	114.16	gnl|BL_ORD_ID|4834|hsp_num:0	5821			6	969	rifampin
BGC0000068.1|Geldanamycin_4 # 11778 # 12071 # -1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=GGGGG;rbs_spacer=13bp;gc_cont=0.741	BGC0000068.1|Geldanamycin_4 	11778	12071	-	Loose	700	23.8682	FOX-9	29.55	3002163	protein homolog model	n/a	n/a	cephalosporin; cephamycin	antibiotic inactivation	FOX beta-lactamase	GTGGCGGACCCGATCACCGAAGTGCACCGGGAGATCACCCGGCTGCTGGCGAAGCTGAGCCGGGCCGGTGGCGGGCGGCCGGACGCCCTCGTGGAGGCGTGCGTCGCCTGTCTGGAGGCCGCACAGTGCACCTCGGCCGCCGCCACCGGGCAGGAGCGGGCGGACACCGGCGCCCAGGAGGCGCTGCACGCGGTCAACGCGGCGGCGCTGGCGATCAGATACGCCCTGGTCAAGGCGGGCGATGAGCGGCGTCTCGCGGCGCGTACCGGGGAGAGCGTGACCTCCGATACGTGA	MADPITEVHREITRLLAKLSRAGGGRPDALVEACVACLEAAQCTSAAATGQERADTGAQEALHAVNAAALAIRYALVKAGDERRLAARTGESVTSDT	MQQRRAFALLTLGSLLLAPCTYASGEAPLTVTVDGIIQPMLKAYRIPGMAVAVLKDGKAHYFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFELDDKVSQHAPWLKGSAFDGVTMAELATYSAGGLPLQFPEEVDSNDKMRTYYRSWSPVYPAGTHRQYANTSIGLFGYLAANSLGQSFEQLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEEKPIRVTPGMLAAEAYGIKTGSADLLKFAEANMGYQGDAAVKSAIALTHTGFYSVGDMTQGLGWESYDYPVTEQVLLADNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLANRNYPIEARVKAAHAILSQLAE	25.39	gnl|BL_ORD_ID|916|hsp_num:0	990			753	1017	
BGC0000068.1|Geldanamycin_5 # 12079 # 14136 # -1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=GGG;rbs_spacer=8bp;gc_cont=0.702	BGC0000068.1|Geldanamycin_5 	12079	14136	-	Loose	575	27.7202	CRD3-1	32.0	3006864	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CRD3 beta-lactamase	GTGCTTGTGCTCGGGCTCAACGGCAACTTCTCCGCCGCGGACACCGATGTGGTGCCGCGGCTGAGCGAGGTCTTCTTCCACGACTCGGCGGCCTCCCTGATCCGCGACGGGGAACTCGTGGCCGCGGTGGAGGAGGAGCGGCTCAACCGGATCAAGAAGACCACCAAATTCCCCATCAACGCGGTCCGTGAGTGCCTGGCCCTGGCCGGCGCGCGGCCCGAGGACGTCGACGCGGTGGGCTACTACTTTCCCGAGAACCACATCGACACCGTCCTCAACCACCTCTACACCGAATATCCGCGGGTGCCCCTGCGCTACTCCCGGGAGCTGATCCGGGAGCGGCTGAAGGAGGGCCTGGACTGGGACCTGCCGGAGGACAAGCTCGTCTATGTGCCGCACCACGAGGCACACGCGTACTCCACATATCTGCACTCCGGCATGGACTCGGCGCTGGTCCTGGTGCTGGACGGCCGGGGCGAACTGCACTCCGGCACCGTCTACCGCGCCGAGGGCACCCACCTGGAGAGGCTGGCCGACTACCCGGTGCCCAAGTCACTGGGCGGGCTCTATCTGAACGCCACCTATCTGCTCGGCTACGGCTTCGGCGACGAGTACAAGGTGATGGGCCTGGCCCCCTGGGGCGACCCCGCGACCTACCGCGACACCTTCTCCAAGCTCTACACCCTCCAGGACAACGGCGAGTACGAACTGCACGGCAACATCATGGTGCCGAACCTGGTCAGCCCGCTGTTCTACGCCGAGGGCTTCCGGCCGCGCCGCAAGAGCGAGCCGTTCACCCAAGCACACCGCGACTTCGCCGCCGCGCTCCAGGAGGCGGTCGAGAAGATCGTGCTGCACATCCTCCAGCACTGGGCGAAGACCAGCGGGCTGTCCCGCCTCTGCTTCGGCGGCGGCGTCGCCCACAACTCCAGCCTCAACGGCCTGATCCTCAAGTCCGGCCTCTTCGACGAGGTGTTCATCCACCCCGCCTCGCACGACGCGGGCGCGGGCGAGGGCGCCGCCTACGCCGCCGCGGCGAGCCTGGGCACTCTCCAACGGCCCCGGAAGCGGCTGCTCAGCGCGAGTCTCGGCCCGGCGCTGGGCACCCGGGAGCGGATCAGGGCACGGCTGGCCGACTGGGCGCCGCTGATCGATGTGGAGTTCCCCGGAGACGCCGTGGAGAGGGCGGCCGGACTGCTCGCCGAGGGCGAGGTGCTCGGCTGGGCGTACGGCCGGTCCGAGTTCGGCCCCCGCGCCCTGGGCCACCGCAGCATCGTCGCGGACGCACGCCCCGAGGAGAACCGGACCCGTATCAACGCGATGGTGAAGAAGCGCGAGGGCTTCCGGCCGTTCGCACCGGTGGTCACCGCCGAAGCCGCCCGCGACTACTTCGACCTCTCCGGCGCGGAGGGCAACCACGAGTTCATGTCCTTCGTGGTGCCGGTGCTGCCGGAGCGGCGTACCGAACTCGGCGCGGTCACCCACGTGGACGGCACCGCCCGGGTGCAGGTCGTCTCGGCCGCCTCGGGCGAGCGCTTCCATCGGCTGGTACGCCGGTTCGGCGAGCTGACCGGCACCCCCGTGCTGCTCAACACCTCCTTCAACAACAACGCCGAACCCATCGTGCAGAGCCTCGACGACGTGGTGACCAGCTTCCTGACCACCGACCTGGACGCCCTGGTGGTGGAGGACTGCCTGGTGCGTGCCAAGCCCTCGCCCGACCTGGGCGTTCTGGTGCCGCGGTTCCGCCCGGTCACCCGGCTGGTCGAGCACAGGACCAGCGGTCCCGACGCCTCGGCGGGCACGAAGGTCCACGAGATCCACCTCGACTACGACGGCGGCCCGTCCGCGAAGGTGTCGCCCGAGCTGTACGAACTGCTCGGCGCGGTGGACGGCACCACCACCCTCGGGGATCTGGCCAAGGCCGTGGGCGGGCTGTCGGAGGCGCTGGCCGCCGAGGTGTTCGCCCTGTGGGAGCAGCGGTTCCTCACCCTCGTCCCGGCCGGGGAGCTCCAGCCGGCCCAGGGGCCCGCGGACGACGGCGCGCGGGGGCGCTGA	MLVLGLNGNFSAADTDVVPRLSEVFFHDSAASLIRDGELVAAVEEERLNRIKKTTKFPINAVRECLALAGARPEDVDAVGYYFPENHIDTVLNHLYTEYPRVPLRYSRELIRERLKEGLDWDLPEDKLVYVPHHEAHAYSTYLHSGMDSALVLVLDGRGELHSGTVYRAEGTHLERLADYPVPKSLGGLYLNATYLLGYGFGDEYKVMGLAPWGDPATYRDTFSKLYTLQDNGEYELHGNIMVPNLVSPLFYAEGFRPRRKSEPFTQAHRDFAAALQEAVEKIVLHILQHWAKTSGLSRLCFGGGVAHNSSLNGLILKSGLFDEVFIHPASHDAGAGEGAAYAAAASLGTLQRPRKRLLSASLGPALGTRERIRARLADWAPLIDVEFPGDAVERAAGLLAEGEVLGWAYGRSEFGPRALGHRSIVADARPEENRTRINAMVKKREGFRPFAPVVTAEAARDYFDLSGAEGNHEFMSFVVPVLPERRTELGAVTHVDGTARVQVVSAASGERFHRLVRRFGELTGTPVLLNTSFNNNAEPIVQSLDDVVTSFLTTDLDALVVEDCLVRAKPSPDLGVLVPRFRPVTRLVEHRTSGPDASAGTKVHEIHLDYDGGPSAKVSPELYELLGAVDGTTTLGDLAKAVGGLSEALAAEVFALWEQRFLTLVPAGELQPAQGPADDGARGR	MFASLIALTLAAQQIIVPLGKTPRPIERPRAPIETAGPLWAEACGDSTDWDQPAPPVRIHGNTYLVGTCGISAILVTGSDGHVLIDGGTEKGAEVIAANIRELGFDLKDIKFLLISHEHFDHVGGIAQLQKLTGATLVASAPAAKVMNSGLPGTDDPQSGMHPPFAPANVGRVVKDSEDVRFGNLMLTAMTTPGHTPGALSWRWESCDGGVCRTMVYADSLSPVSRDDYKFSGHPAYLAAYRASIAKVAATRCEILLTPHPSASAMKERMTGKQALFDADGCRDYAAALTRRLDERLAKEKAK	226.07	gnl|BL_ORD_ID|3411|hsp_num:0	4480			78	282	
BGC0000068.1|Geldanamycin_6 # 14198 # 15310 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AAG;rbs_spacer=8bp;gc_cont=0.716	BGC0000068.1|Geldanamycin_6 	14198	15310	-	Loose	275	25.409	AAC(6')-I30	31.58	3002588	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGACGGAGGGGAAGCCCGTGAGCGAGCCGCCGGCGGCCGTCAAATGTCTCGTCTGGGACCTCGACAACACACTCTGGCGCGGCACCCTGCTCGAGGACGGCGAGGTGCCGCCGTTCGCATGGGTGCGCGATGTCATCACCACCCTCGACGACCGCGGCATTCTCCAGTCGATCGCCAGCAAGAACGACCACGACCACGCCTGGGCGCGCCTGGAGGCGCTGGGCCTCGCCGAGTACTTCGTGCTGCCGCACATCGGCTGGGGGCCCAAGTCGGAATCGGTGCGTGCCATCGCGGAGCGGCTGAACTTCGCACACCGTGCCATGGCCTTCGTGGACGACCAGCCCGCCGAGCGCGCCGAGGTCGGCTACCGGCTCCCCGAGGTGCGCTGCTACACCGCCGAGGACGTGGCCGGACTCACCGGGCTGCCCGAGTTCAGCCCCGCCGTGGTCACCGTGGACTCACGGCAGCGGCGCACCATGTACCAGTCGGGGTTCCGCCGTGACGCCGAGCGGGCGGAGTTCGGCGGACCCGACGAGGAGTTCCTGCGCACCCTGGACATCGAGATGGCCATCTCCCGCGCCACCGAGCGGGAGCTGTCCCGGGTCGAGGAACTGACCCTGCGCACCAGCCAGATGAACGCCACCGGTGTGCACTACTCCGACTCCGTACTGCGCGGACTGCTCACCGACCCCGCGCACGAGGTGCTGGTCATCACGATGGCCGACCGGTTCGGCCCGCACGGCGCCGTCGGCATCGTGCTGCTGGAACGCCACCCGGCGGTGTGGCATCTGAAACTGCTCGCCACCTCCTGCCGTGTGGTCTCCTACGGCGCCGGGTCCACCCTGCTGAACTGGCTGGCCGACCAGGCGGCGCGTGCCGGGGTGCATCTGGCCGCCGACTTCCGGCGCACCGACCGCAACCGGATGATGGAGGTCGCCTACCGCTTCGCCGGGTTCGCCGACGCCGACTGCGCCTGCACCGCCGCCCTCGCGGCCCCCGGCGAGGAGGGCGTCGAACGCCTCCACCTCACCCCCGCGTTCCAGCCGGCCCCGACCACGCTGCGGCTGACCGCGCCTGAGCTCGCCGACGCGGCGCTGCCGCGCTCCCGGTGA	MTEGKPVSEPPAAVKCLVWDLDNTLWRGTLLEDGEVPPFAWVRDVITTLDDRGILQSIASKNDHDHAWARLEALGLAEYFVLPHIGWGPKSESVRAIAERLNFAHRAMAFVDDQPAERAEVGYRLPEVRCYTAEDVAGLTGLPEFSPAVVTVDSRQRRTMYQSGFRRDAERAEFGGPDEEFLRTLDIEMAISRATERELSRVEELTLRTSQMNATGVHYSDSVLRGLLTDPAHEVLVITMADRFGPHGAVGIVLLERHPAVWHLKLLATSCRVVSYGAGSTLLNWLADQAARAGVHLAADFRRTDRNRMMEVAYRFAGFADADCACTAALAAPGEEGVERLHLTPAFQPAPTTLRLTAPELADAALPRSR	MAYAFCEIGESNEYIIQAARILTKSFLDIGNDSWPDMKSATKEVEECIEKPNICLGIHENEKLLGWIGLRPMYKLTWELHPLVISTQYQNKGIGRLLINELEKQAKQNGIIGIVLGTDDEYFKTSLSDVDLSGKNILDEIRNIKNIRNHPYEFYQRCGYSIVGVIPDANGKRKPDIWMWKKISD	201.09	gnl|BL_ORD_ID|1251|hsp_num:0	1365			216	330	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0000068.1|Geldanamycin_7 # 15307 # 16419 # -1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=GGG;rbs_spacer=8bp;gc_cont=0.735	BGC0000068.1|Geldanamycin_7 	15307	16419	-	Loose	350	27.7202	Trimethoprim-resistant dihydrofolate reductase DfrA43	28.36	3005345	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	GTGACCGACGCCGCCACCGACCACGCGGAGCTGGTCAGCGGGTTGATCGGGGACCGGGCCGACGCCTGGGACCTGGCCGGGGAACTGCCCCGCGACCTCCTGGTCAAACTCGGCGCCTCCGGTGTGCTGTGCGCACAGGTCGGCCCCGAGCACGGCGGCACCGGACTGGACAGCCATGCCAACGGGGAGCTCACCGCGCGGGTCGGCGCCCGGTGCAGCTCCCTGCGCAGCGTGATGACCTCGCAGGGCATGGCGGCGTGGACGGTGCGCAGGCTCGGCGGCACCGAGCAGTGGGACACCTTTCTGCCCCGGCTGACCTCCGGTGACCTGGCGGCGGTCGGATTCAGCGAACCCGGCGCCGGCAGCGACCTGTCGGCGATGGAGACCGAGATCGCCGACGACGGCGCCGAGGTGGTCGTCACCGGACGGAAGGTGTGGATCACCGCCGCCCACTACGCCGATCTGCTGCTGGTGTTCGGGAAGTACCGGGGCGGCGCCACGGCCGTGGTCGTGCCCGCCCGGACACCCGGAGTGCGCATCACACGGGTGGAGAACCCCCTGGGCTGCCGCGCCGCCGGTCATGCGAACATCACCCTGGACGCGGTCCGGGTGCCCGCCGGGCATGTACTCGGCGGCACCGGGCTGCCGCTTTCCCTGGCGACCACCGCCGCGCTCACCTACGGGCGCATGTCCGTGGCCTGGGGGTGCGTCGGCATCCTGCGCGCGTGCCTGGACGCCGCCGCCACGCACACCGCCACCCGGGAGCAGTCCGGCCGGGCGCTCGCCGAGCACCAGTTGGTGGCCCGGCACCTGGCCGAGCTGTACGTCGCGGAGCGGCACGCCACCCGGGCCTGTGAACACGCCAGCGCCTCCTGGGACACCGGCTCGCCCGACATGGCCGTCGACGCGGTGCACGCGAAGTACGTCGCCTCGCGCGAGGCGGCACAGGGCGCGGCACGCGCCGTACAGCTCCTGGCGTCGGCCGGGGCGTCCGACGGCCATGTGGTGGCCCGTGCCTACCGCGACGCGAAGCTGATGGAAGTCATCGAGGGCACCAGCGAGATCTGCCAGCTCGTGCTCGCCCGGCACATGCGGAAGAAGGTGCGACCATGA	MTDAATDHAELVSGLIGDRADAWDLAGELPRDLLVKLGASGVLCAQVGPEHGGTGLDSHANGELTARVGARCSSLRSVMTSQGMAAWTVRRLGGTEQWDTFLPRLTSGDLAAVGFSEPGAGSDLSAMETEIADDGAEVVVTGRKVWITAAHYADLLLVFGKYRGGATAVVVPARTPGVRITRVENPLGCRAAGHANITLDAVRVPAGHVLGGTGLPLSLATTAALTYGRMSVAWGCVGILRACLDAAATHTATREQSGRALAEHQLVARHLAELYVAERHATRACEHASASWDTGSPDMAVDAVHAKYVASREAAQGAARAVQLLASAGASDGHVVARAYRDAKLMEVIEGTSEICQLVLARHMRKKVRP	MHMKMNIIVAMHEASRGIGINGELPWRIPEDMAHFARVTQKSVVIMGRKTWYSIPPKFRPLKNRLNIVLSRDPETRASIVSNTPGCMAFASLELCLQYLRQLHPSTIVFAIGGSSLYKEILAMQMLCERIYMTLVSGGPKTHSFDTFFPEIDETVYSKRICGGSGEHDDWKYKFVIYERPTSESVQSIETISQGH	189.74	gnl|BL_ORD_ID|3051|hsp_num:0	4077			126	300	trimethoprim
BGC0000068.1|Geldanamycin_8 # 16416 # 16691 # -1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=AAG;rbs_spacer=8bp;gc_cont=0.659	BGC0000068.1|Geldanamycin_8 	16416	16691	-	Loose	400	23.483	QnrB4	28.57	3002718	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	GTGACCATCTCATCCGAGCAGGGCAGCCACACCGCCGAGACGGTGGCGCGGGAGGTGCAGCAGTTCCTCGAACAGCGCACCAAGCAGACCTGGGACCCGGACACCGACCTGTTCAGCACCGGCGCCGTGTCCTCGATGTTCGCCATGGAACTGGTCGTGCACCTGGAGTCGTCCTTCGACGTGGTGATCAGCGGCCCCGATCTGGCGCTGGACAACTTCCGTACGGTGAACGCGATGACCGCGATGGTCCTGCGGCTGCGCGGGGTCAAGCCGTGA	MTISSEQGSHTAETVAREVQQFLEQRTKQTWDPDTDLFSTGAVSSMFAMELVVHLESSFDVVISGPDLALDNFRTVNAMTAMVLRLRGVKP	MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG	42.52	gnl|BL_ORD_ID|1568|hsp_num:0	1707			186	270	ciprofloxacin; levofloxacin; moxifloxacin; gatifloxacin; nalidixic acid; norfloxacin; sparfloxacin
BGC0000068.1|Geldanamycin_9 # 16688 # 17641 # -1 # ID=1_9;partial=00;start_type=TTG;rbs_motif=GGGGGG;rbs_spacer=13bp;gc_cont=0.704	BGC0000068.1|Geldanamycin_9 	16688	17641	-	Loose	750	28.4906	tet(X6)	32.43	3005056	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	TTGCGTGACCGCCCCGAGAATATCGTGAACGCGACAAGCGCGTGTCATGGTCGGCACGTTGTTCACAACGCGCTGCGGAGGCGATTGATGAGCGGACATGCGGAAGCGCACCGGCTCATGGTGCTGGGTGCGGGAACAATGGGACTGGGGATCACCTCTCTCGCCGTGGGGCACGGAATCCCGGTGACGGTCGTCGAGGTGGACGAGGCCAAGGCCGGCCGGACGCGGGCCGCGGTCACCGAACGGCTCCGCATGGCCCAGCTCATGCGGGCCCTGCCCGCCGACCGGCCGCCCGGCGAGCTGACGGTCACCGCGTCCCCGGCCGACGGCCGGGAGGCCACCGCCGTGGTGGAGGCCGTCACCGAGGACACCCCCACCAAGGCCAAGGTGCTCGAAGCGGTCGCCGGGCTCACCGGCGGGCGGGTGCCGCTGATCTCGAACACCTCCTCCATCCCGATCGACGAACTGGCCGGTTTCATCGCCGATCCGGCACGGCTGGTCGGCACCCACTTCATGAACCCGCCCTATCTGATCCCCACGGTGGAGGTGATCCGCGGCCCCCGTACCGGGGAAGCGGCGATGGCCGCCGTGACGGATCTGCTGCGCGCGCTGGAGCGCAAGCCGGTCGTCGTCGGCGACGGGCCGGGGTTCGTCACCAGCCGGGTGCTGCACCCGATGATCAACGACGCGATCCGTGTGGTGCAGGAGGGCACGGCGACGGCGGAGGCCGTGGACGTCCTCATGCGGGACTGCCTGGGCCACCGCACCGGACCGCTGCGCACCGCGGACCTGATCGGCCTGGACAACCTCGCCGACTCGCTGCGCGTGCTGCATGAACGCACCGGCGACGCCCGGTGCGCACCGAGCGAATTGCTGCTGGAGAAGGTCCGCGACGGCCATCTGGGCCGCAAGTCGGGCCGCGGGTTCTACGCATACGGGAAGGAGCTGGCGTGA	MRDRPENIVNATSACHGRHVVHNALRRRLMSGHAEAHRLMVLGAGTMGLGITSLAVGHGIPVTVVEVDEAKAGRTRAAVTERLRMAQLMRALPADRPPGELTVTASPADGREATAVVEAVTEDTPTKAKVLEAVAGLTGGRVPLISNTSSIPIDELAGFIADPARLVGTHFMNPPYLIPTVEVIRGPRTGEAAMAAVTDLLRALERKPVVVGDGPGFVTSRVLHPMINDAIRVVQEGTATAEAVDVLMRDCLGHRTGPLRTADLIGLDNLADSLRVLHERTGDARCAPSELLLEKVRDGHLGRKSGRGFYAYGKELA	MTLLKHKKITIIGAGPVGLTMARLLQQNGVDITVYERDKDQDARIFGGTLDLHRDSGQEAMKRAGLLQTYYDLALPMGVNIVDEKGNILTTKNVRPENRFDNPEINRNDLRTILLNSLQNDTVIWDRKLVTLEPDKEKWILTFEDKSSETADLVIIANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKSKTRVDFQDRNSVVDFLLKKFSDWDERYKELIRLTSSFVGLATRIFPLDKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFAYGREAQAESIINETEMFSLDFSFQKLMNL	83.86	gnl|BL_ORD_ID|4802|hsp_num:0	3797			21	132	tetracycline; minocycline; oxytetracycline
BGC0000068.1|Geldanamycin_10 # 17818 # 18456 # 1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=AAG;rbs_spacer=5bp;gc_cont=0.684	BGC0000068.1|Geldanamycin_10 	17818	18456	+	Loose	500	33.8834	lnuB	23.02	3002836	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic inactivation	lincosamide nucleotidyltransferase (LNU)	GTGACCGAAGAAATTCTCGGCTATGTCCGGGAACTGTCCCTGCGCGACGACGAGGTCCTGGCCGGGCTGCGGGCGGAAACCGCGGGTCTGCCGGCCGCACAGGCCATGCAGGTGATGCCCGAGGAGGGTCAGCTCCTCGGGCTGCTGGTGCGGCTCGTCGGTGCCCGTTCGGTGCTGGAGATCGGCACCTTCACCGGCTACAGCACACTGTGCATGGCGCGGGCCCTGCCGGCCGACGGCACGCTGATCACCTGCGACATCACGGAGAAGTGGCCGGGGCTCGGGCGTCCGTTCTGGGAGCGCGCCGAAGTGGCGGACCGCATCGATGTGCGCATCGGTGACGCGAAGGACACACTGGCCGGACTGCGGCGGGCGGGCCGGGAGTTCGACCTGGTCTTCATCGACGCGGACAAGACCGGCTACGCGCACTATTACGAGGAGTCACTGGCGATGCTCCGGCGCGGCGGCCTCATCGTCCTGGACAACACCCTCTTCTTCGGCCGGGTGACCGACCCCGCCGCACAGGACGCCGACACCGCCGCCCTGCGCGAGATGAACAAACTGCTCCGGGAGGACGGACGCGTCGAGATCAGCATGCTCACCGTGGGCGATGGGATCACGCTGGCGGTCAAACGCTGA	MTEEILGYVRELSLRDDEVLAGLRAETAGLPAAQAMQVMPEEGQLLGLLVRLVGARSVLEIGTFTGYSTLCMARALPADGTLITCDITEKWPGLGRPFWERAEVADRIDVRIGDAKDTLAGLRRAGREFDLVFIDADKTGYAHYYEESLAMLRRGGLIVLDNTLFFGRVTDPAAQDADTAALREMNKLLREDGRVEISMLTVGDGITLAVKR	MLKQKELIANVKNLTESDERITACMMYGSFTKGEGDQYSDIEFYIFLKHSITSNFDSSNWLFDVAPYLMLYKNEYGTEVVIFDNLIRGEFHFLSEKDMNIIPSFKDSGYIPDTKAMLIYDETGQLENYLSEISGARPNRLTEENANFLLCNFSNLWLMGINVLKRGEYARSLELLSQLQKNTLQLIRMAEKNADNWLNMSKNLEKEISLENYKKFAKTTARLDKVELFEAYKNSLLLVMDLQSHLIEQYNLKVTHDILERLLNYISE	79.40	gnl|BL_ORD_ID|741|hsp_num:0	809			255	582	lincomycin; clindamycin
BGC0000068.1|Geldanamycin_12 # 21660 # 22724 # -1 # ID=1_12;partial=00;start_type=TTG;rbs_motif=AAG;rbs_spacer=6bp;gc_cont=0.726	BGC0000068.1|Geldanamycin_12 	21660	22724	-	Loose	900	26.9498	AAC(6')-Ie-APH(2'')-Ia bifunctional protein	34.38	3002597	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	aminoglycoside bifunctional resistance protein	TTGACCACGTCGACCTCCAGTCCGGCCGCCAGTTCCGCCGCTCCTTTCCGGCAGGTCACCGTCGCGCTGGCCGAGCGCTCGTACACCGTCCACATCGGACACGGTGTGCGGCGGCTGCTCCCGAGGGTGGTGTCCGCCCTGGGCGCGCGCAAGGCGGTGGTGGTCACCGCGCGGCCCCCGGAGCAGACGCCCGACCCCAAAGTGCCCTCGCTCGTCGTGTCCACGCGCGACGGGGAGGAGGCCAAGGACCTGGCCGCCGTGACGGACCTGTGCCGCCGGTTCGTCGAATTCGGGCTGACCCGCTCGGATGTGGTGGTGTCCTGTGGCGGCGGCACCACGACCGACACGGTGGGCCTGGCCGCCGCCCTCTACCACCGGGGCACACCGGTCGTCCATGTGCCGACCTCGCTGCTGGCCCAGGTGGACGCGAGCGTCGGCGGGAAGACGGCGGTGAATCTGCCCGAGGGCAAGAACCTGGTCGGCGCCTACTGGCAGCCCGCGGCCGTGCTCTGCGACCTCGATCACCTCACCACCCTGCCCGAACGGGAGTGGCGCAACGGCCTCGGTGAGATCGCCCGCTGCCACTTCATCGGCGCGCCCGATCTCGACGGGCTGCCGCTGCTCGACCAGATCGCGGCCAGTGTGACGCTCAAGGCGGGCATCGTCGCCGCGGACGAACGCGACGCGGGCTTGCGGCACATCCTCAACTACGGACACACACTGGGGCATGCGCTGGAACGTGCCACGGGGTTCGCCCTGCGGCACGGGGAGGGCGTGGCCATCGGCACGGTCTTCGCCGGCCGGCTCGCCGGTGCGCTGGGCCGTATCGGCCCGGAGCGGGTGGCCGAGCACCATGATGTGGTCGCCCGTTACGGCCTGCCGACCGCGCTGCCCGCCCAGGTCCCCGTGGCCGAGCTGGTGGAGCTGATGCGTCTGGACAAGAAGGCCACCGACGGGCTGACGTTCGTCCTGGACGGCCCCGACGGGCCCGGACTGGTGCCCGGGATCCCCGAGGACACCGTCAGCGCCACCCTCGCCGCGATGCCCCGCGAGCCGGCGGGGTGA	MTTSTSSPAASSAAPFRQVTVALAERSYTVHIGHGVRRLLPRVVSALGARKAVVVTARPPEQTPDPKVPSLVVSTRDGEEAKDLAAVTDLCRRFVEFGLTRSDVVVSCGGGTTTDTVGLAAALYHRGTPVVHVPTSLLAQVDASVGGKTAVNLPEGKNLVGAYWQPAAVLCDLDHLTTLPEREWRNGLGEIARCHFIGAPDLDGLPLLDQIAASVTLKAGIVAADERDAGLRHILNYGHTLGHALERATGFALRHGEGVAIGTVFAGRLAGALGRIGPERVAEHHDVVARYGLPTALPAQVPVAELVELMRLDKKATDGLTFVLDGPDGPGLVPGIPEDTVSATLAAMPREPAG	MNIVENEICIRTLIDDDFPLMLKWLTDERVLEFYGGRDKKYTLESLKKHYTEPWEDEVFRVIIEYNNVPIGYGQIYKMYDELYTDYHYPKTDEIVYGMDQFIGEPNYWSKGIGTRYIKLIFEFLKKERNANAVILDPHKNNPRAIRAYQKSGFRIIEDLPEHELHEGKKEDCYLMEYRYDDNATNVKAMKYLIEHYFDNFKVDSIEIIGSGYDSVAYLVNNEYIFKTKFSTNKKKGYAKEKAIYNFLNTNLETNVKIPNIEYSYISDELSILGYKEIKGTFLTPEIYSTMSEEEQNLLKRDIASFLRQMHGLDYTDISECTIDNKQNVLEEYILLRETIYNDLTDIEKDYIESFMERLNATTVFEGKKCLCHNDFSCNHLLLDGNNRLTGIIDFGDSGIIDEYCDFIYLLEDSEEEIGTNFGEDILRMYGNIDIEKAKEYQDIVEEYYPIETIVYGIKNIKQEFIENGRKEIYKRTYKD	73.90	gnl|BL_ORD_ID|4823|hsp_num:0	1814			1245	1341	dibekacin; amikacin; sisomicin; netilmicin; kanamycin A; tobramycin; gentamicin A; 2'-N-ethylnetilmicin; 5-episisomicin; gentamicin
BGC0000068.1|Geldanamycin_15 # 24390 # 26147 # -1 # ID=1_15;partial=00;start_type=GTG;rbs_motif=AAG;rbs_spacer=9bp;gc_cont=0.667	BGC0000068.1|Geldanamycin_15 	24390	26147	-	Loose	500	26.1794	TEM-205	33.33	3001382	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam; penem	antibiotic inactivation	TEM beta-lactamase	GTGCTCTGGCACGCGGCCCAGAAGAATCTCGACGAGGGCCGTACGGAAGAAGCGGTCGCCGGTCTGCGGCTGGCCGCTCGCGCCGATCTCGGCCGGCGGGAGCGCCTGGACATTCGCATGGCGCTGGTCGGCGCGTTATGGGCCGGCAATCCGGCGGCCGCCGAACCCGAGCTCGACCGGCTGATGGCCGCGATACGGACCGAATCCCCCGCGGACATCCCCGAGCAGTATCTGTGCTTCCTGCTCTTCATGGTGCTGTGGTTCGGCCGGTTCAGCGATGTCGAAGAAGCCTTCACATGGCTGTCGGGCAGTGGTGGCTCCGGTAATGCGTCCAGTATGGCGGCGCTGCGGGTGACCCGGCAGTGGGTCACCTTCCTCAAACCGACGCTGATCCACCACTTCCCCGACCAGGATCCCTCGGACAGGGAAGTCGACGGGCTGTGGGCGGCCAATCTGGAGCACGGACTCCAGCTCTCCGTGGACGAACTGGGCATGGAGATCGGGCATCTCCAGGATCCCCGGCAGATGGCGGACTTCTCCCCCGACACCATGCACCTGTTGTCGCACTCCAACCATTTCTGGTTCGCCTACGCGTACGCCTGCCGGATCGTCTGGGCACTGGCCGCGAGGGGAGAGACGGAGGCGGCGGACCGGCTGTGCGGGGCGCTGTTCACCGCGGCGGACAAGCTCAATATGAAGACGCCGTGTGCCGTCGCCCTGTCCATGCGTGCCTATATCCAGTGCCGCCAGGGGGACTTCACCTCGGCCATCGATCTCGCCGGCACCGCGCTGAGGTCCATCCCGCCACGCGGCTGGGGCGTCGCCATCGGGTTACCGCTGTCCGTGCTGGTGGCGGCCCACACCGCCATCGGCAGGCTGGACGAGGCCCAGCGGTATCTGCGTTACTGGGTGCCGAAGGAGATGTTCGACAGCGTTGTCGGATTGGAGTACCTCCGGGCCCGGGGGCAATACTGCCTGGCCACCAACCGCCCCTATGCCGCGCTGAACGATTTCATGGTGAGCGGGATGCTGATCGACCAGTGGCCCGTGGACTTCGGTGATCTGGCACCCTGGCGCATCGACGCCGCCGAGGCATATCTGCACGTACATGAACCCGTGGAGGCCAAAAGGCTCGCCCTGGAAGAGCTCAAGCTGTCGCCCGACCGCCCCATGAGCACCCGCGGCAGAGCGCTGCGCGTACTGGCCATGGCGGAGGACCCGGACAAACGCAGGCTGCTGCTCTACCAATCCGTCAAGTGCCTGCGCGAGCACGGCGACCGTTATGGACTCGCCCGCACGCTCGTCGAACTCAGCCGGGACTTCCTCAGCACCGGGGAAACCCAGCAGGCGCGCGCCACCTGGCATGAGGCGCAGAAGCTGATGGACGAGTGCGGAATGAGCGCCCAGCACGAGAGCCGACGGGACCCCGTCATGGGCGGTGCCGAGAGCCCGGCGGACCCTCAACCGCCGGGAAATTCCGAGGATTCCGGGGAGCCCGGGGTACCCGAGGATACGGCCCTGGGCACATCGGCCGAAGATGCCGAGCCACCCGTACTTTCGGAGGCCGAATGGCGCGTGGCCACCCTCGCGGCGTCGAGAATGACCAACCGGCAGATCGCCAAGAGCCTCTACATCACCGTCAGCACCGTGGAGCAGCATCTGACCCGCGTCTACCGCAAGCTCTCCGTGGGAAATCGACAGGATCTGTCGCGCCGCCTGTGGCCGCTCATAGGAGCCACCGGATCGTCCTCCTGCTGA	MLWHAAQKNLDEGRTEEAVAGLRLAARADLGRRERLDIRMALVGALWAGNPAAAEPELDRLMAAIRTESPADIPEQYLCFLLFMVLWFGRFSDVEEAFTWLSGSGGSGNASSMAALRVTRQWVTFLKPTLIHHFPDQDPSDREVDGLWAANLEHGLQLSVDELGMEIGHLQDPRQMADFSPDTMHLLSHSNHFWFAYAYACRIVWALAARGETEAADRLCGALFTAADKLNMKTPCAVALSMRAYIQCRQGDFTSAIDLAGTALRSIPPRGWGVAIGLPLSVLVAAHTAIGRLDEAQRYLRYWVPKEMFDSVVGLEYLRARGQYCLATNRPYAALNDFMVSGMLIDQWPVDFGDLAPWRIDAAEAYLHVHEPVEAKRLALEELKLSPDRPMSTRGRALRVLAMAEDPDKRRLLLYQSVKCLREHGDRYGLARTLVELSRDFLSTGETQQARATWHEAQKLMDECGMSAQHESRRDPVMGGAESPADPQPPGNSEDSGEPGVPEDTALGTSAEDAEPPVLSEAEWRVATLAASRMTNRQIAKSLYITVSTVEQHLTRVYRKLSVGNRQDLSRRLWPLIGATGSSSC	MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTTPVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW	204.55	gnl|BL_ORD_ID|644|hsp_num:0	698			519	690	ampicillin
BGC0000068.1|Geldanamycin_16 # 28045 # 28356 # 1 # ID=1_16;partial=01;start_type=GTG;rbs_motif=GGG;rbs_spacer=10bp;gc_cont=0.724	BGC0000068.1|Geldanamycin_16 	28045	28356	+	Loose	550	23.0978	vgbA	30.0	3001307	protein homolog model	n/a	n/a	streptogramin antibiotic; streptogramin B antibiotic	antibiotic inactivation	streptogramin vgb lyase	GTGACCGTCAAGGGCGCGCTGTTCGACTTCTCCGGGACGCTGTTCCGAATCGAGTCCACCGAGTCCTGGCTGCGCACCGTGCTGGAGCGGAGCCGGACCGTCCTCCCGGAGGAGGAGTTCGTACGGTACGCACGGGCCCTGGAGGACGCCGGTGCGCTTCCCGGCGGCGCGGCGCCACTCGCGGTGCCGCCGCCTCTGGAGGAGGTGTGGGGCGTACGGGACCGCAGTGCCGAGTCGCACCGGGCGGCCTACACCGGTCTGGCCCGCGAGGTGCCGCTGCCCCGCCCCGAGTTCTACGACGCCCTCTATGAC	MTVKGALFDFSGTLFRIESTESWLRTVLERSRTVLPEEEFVRYARALEDAGALPGGAAPLAVPPPLEEVWGVRDRSAESHRAAYTGLAREVPLPRPEFYDALYD	MEFKLQELNLTNQDTGPYGITVSDKGKVWITQHKANMISCINLDGKITEYPLPTPDAKVMCLTISSDGEVWFTENAANKIGRITKKGIIKEYTLPNPDSAPYGITEGPNGDIWFTEMNGNRIGRITDDGKIREYELPNKGSYPSFITLGSDNALWFTENQNNAIGRITESGDITEFKIPTPASGPVGITKGNDDALWFVEIIGNKIGRITPLGEITEFKIPTPNARPHAITAGAGIDLWFTEWGANKIGRLTSNNIIEEYPIQIKSAEPHGICFDGETIWFAMECDKIGKLTLIKDNME	34.78	gnl|BL_ORD_ID|4682|hsp_num:0	1594			204	294	pristinamycin IA; quinupristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3
